Thought Leadership
Old Drug, New Tricks? How the BPCIA Could Increase Generic Competition for Insulins
June 23, 2020
Ted Mathias, Stacie Ropka and Rebecca Clegg
BioProcess Online / Biosimilar Development

BioProcess Online and Biosimilar Development published "Old Drug, New Tricks? How the BPCIA Could Increase Generic Competition for Insulins," an article written by Axinn partners Ted Mathias and Stacie Ropka and associate Rebecca Clegg.

Click to access the article on BioProcess Online and Biosimilar Development

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.